| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 128,062 | 121,528 | 110,364 | 112,413 | | Cost of Revenue | 53,605 | 49,838 | 42,904 | 44,825 | | | Gross Profit | 74,457 | 71,690 | 67,460 | 67,588 | | | Operating Expenses | | Research Development | 20,497 | 20,670 | 20,862 | 20,363 | | Selling General and Administrative | 25,001 | 24,885 | 23,697 | 25,713 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 28,959 | 26,135 | 22,901 | 21,512 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,665 | 2,932 | (1,695) | (260) | | Earnings Before Interest And Taxes | 31,624 | 29,067 | 21,206 | 21,252 | | Interest Expense | 613 | 609 | 603 | 609 | | Income Before Tax | 31,011 | 28,458 | 20,603 | 20,643 | | Income Tax Expense | 9,428 | 9,619 | 5,419 | 3,934 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,583 | 18,839 | 15,184 | 16,709 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,583 | 18,839 | 15,184 | 16,709 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,583 | $18,839 | $15,184 | $16,709 |
|
0.51% Nasdaq 
Income Statement
